NCT00440245View on ClinicalTrials.gov

Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
AsthmaCOPD
Interventions
DRUG

salbutamol

200 micrograms salbutamol from MDI

Trial Locations (1)

S7N0W8

University of Saskatchewan, Saskatoon

All Listed Sponsors
lead

University of Saskatchewan

OTHER

NCT00440245 - Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter